WO2020192163A1 - Refined american ginseng total saponin component and method for purifying and preparing american ginseng total saponin - Google Patents
Refined american ginseng total saponin component and method for purifying and preparing american ginseng total saponin Download PDFInfo
- Publication number
- WO2020192163A1 WO2020192163A1 PCT/CN2019/121266 CN2019121266W WO2020192163A1 WO 2020192163 A1 WO2020192163 A1 WO 2020192163A1 CN 2019121266 W CN2019121266 W CN 2019121266W WO 2020192163 A1 WO2020192163 A1 WO 2020192163A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- american ginseng
- refined
- purification
- total saponins
- column
- Prior art date
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/15—Preparation or pretreatment of starting material involving mechanical treatment, e.g. chopping up, cutting or grinding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/55—Liquid-liquid separation; Phase separation
Definitions
- the present invention provides a refined American ginseng total saponins component and a method for purifying and preparing the American ginseng total saponins.
- the purification preparation method includes the following steps:
- the type of the filtration membrane is an organic membrane or an inorganic membrane
- the membrane module is a flat membrane, a tubular membrane, a hollow fiber membrane or a roll type
- the pore size is 750kD ⁇ 1000kD, 0.1-0.65 ⁇ m
- the packing matrix of the reversed-phase chromatographic column used in high performance liquid chromatography technology is silica gel or high molecular polymer; one or more of the normal chain alkyl groups with 1-30 carbon atoms of the packing ligand; the inner diameter of the chromatographic column is 20mm ⁇ 1600mm, the height of the chromatographic column bed is 100mm ⁇ 1000mm; the chromatographic balance liquid contains organic solvent; the sample loading amount of the chromatographic column is 0.01% ⁇ 60% of the weight of the stationary phase; the sample loading and elution flow rate of the chromatogram is 140cm/h ⁇ 350cm/h; the organic solvent concentration for chromatographic purification and elution of the total saponin target component is 30-9
- the operating parameters related to the total saponins of American ginseng are safe and controllable, and the external interference factors are small, which can significantly improve the quality of the product;
- the present invention provides a purification preparation method for extracting panax quinquefolium saponins, and the specific steps are as follows:
- the present invention provides a method for preparing total saponins in American ginseng medicinal materials, and the specific steps are as follows:
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
Abstract
A method for extracting and purifying American ginseng total saponin, and American ginseng total saponin prepared using said method; using American ginseng as the raw material, extracting a crude extract solution using ethanol, clarifying using membrane filtration techniques, using high performance liquid chromatography techniques to implement refinement, and using ion exchange gel chromatography to decolourise and remove impurities.
Description
本发明涉及一种中药制备工艺,主要涉及一种应用高效液相制备和离子交换色谱技术制备西洋参总皂苷的方法。The invention relates to a preparation process of traditional Chinese medicine, and mainly relates to a method for preparing panax quinquefolium saponins by applying high-performance liquid phase preparation and ion exchange chromatography technology.
西洋参(学名:Panax quinquefolius)是五加科人参属多年生草木植物,具有滋阴补气,宁神益智及清热生津,降火消暑的双重功效,补而不燥是西洋参的特别之处;现代药理研究表明西洋参中的皂苷还具有保护心血管系统、增强中枢神经系统功能、提高免疫力等作用。目前西洋参药物制剂的剂型为液体和固体两种,为保留西洋参有效成分,在固体剂型中常将药物以细粉方式投料,直接加入胶囊剂、片剂等中;而液体制剂需将西洋参中有效成分最大限度提出,还需保证制剂外观澄清,所以提取制备的纯化工艺为其中关键。American ginseng (scientific name: Panax quinquefolius) is a perennial plant of the genus Araliaceae ginseng. It has the dual effects of nourishing yin and nourishing qi, calming the mind, nourishing the mind and nourishing energy, clearing heat and promoting fluid, reducing heat and relieving heat. It is the special feature of American ginseng to nourish but not dry; Pharmacological studies have shown that the saponins in American ginseng can also protect the cardiovascular system, enhance the function of the central nervous system, and improve immunity. At present, the dosage forms of American ginseng medicinal preparations are liquid and solid. In order to retain the effective ingredients of American ginseng, the medicines are often dosed in the form of fine powder in the solid dosage form and directly added to capsules, tablets, etc.; while liquid preparations require the effective ingredients of American ginseng As far as possible, it is necessary to ensure that the appearance of the preparation is clear, so the purification process of extraction and preparation is the key.
西洋参中化学成分多而复杂,皂苷是最主要的有效成分之一,也是生理活性最显著的物质,其中三萜皂苷类化合物起主要作用,其中人参皂苷Rb1的含量最多,具影响动物睾丸的潜力,亦会影响小鼠的胚胎发育,具有增强胆碱系统的功能,增加乙酰胆碱的合成和释放以及改善记忆力作用。The chemical components in American ginseng are many and complex. Saponins are one of the most important effective components and the most significant physiologically active substances. Among them, triterpene saponins play a major role. Among them, ginsenoside Rb1 has the most content, which has the potential to affect animal testes. , It also affects the embryonic development of mice, has the function of enhancing the choline system, increasing the synthesis and release of acetylcholine and improving memory.
目前西洋参总皂苷常用的制备分离方法有液-液萃取法、沉淀法、吸附法等。At present, the commonly used preparation and separation methods for total saponins of American ginseng include liquid-liquid extraction, precipitation, and adsorption.
液-液萃取法由于多用二氯甲烷、氯仿、苯等脱脂,不但易造成有效成份的损失,The liquid-liquid extraction method uses dichloromethane, chloroform, benzene and other degreasing methods, which not only easily causes the loss of effective ingredients,
而且由于有机溶剂有毒性,生产工艺上来讲不安全,甚至使产品中残留部分溶剂降低产品质量。沉淀法常用的沉淀剂是铅盐,它能与许多物质生成难溶的铅盐或络合物,选择性差;同时铅盐有剧毒,严重影响产品质量。吸附法中常见的吸附剂有硅胶、氧化铝、活性聚酞胺、硅藻土。目前,对西洋参总皂苷的分离多采用柱层析法,常采用过大孔吸附树脂柱。但大孔树脂吸附分离技术存在缺点:(1)有机残留物高,预处理难度大;(2)强度差,使用过程中破碎严重,使用寿命短;(3)粒径分布广,分离效果差;(4)同一生产企业生的同一型号树脂,各批之间比表面积和功能基团含量差别大,在中药成分纯化中重现性差等。Moreover, due to the toxicity of organic solvents, the production process is not safe, and even the residual solvents in the product reduce the product quality. The commonly used precipitant in the precipitation method is lead salt, which can form insoluble lead salts or complexes with many substances, with poor selectivity; at the same time, lead salts are highly toxic and seriously affect product quality. Common adsorbents in the adsorption method are silica gel, alumina, active polyphthalamide, and diatomaceous earth. At present, the separation of the total saponins of American ginseng mostly adopts column chromatography, and often adopts a large-pored adsorption resin column. However, the macroporous resin adsorption and separation technology has disadvantages: (1) high organic residues, difficult pretreatment; (2) poor strength, severe breakage during use, and short service life; (3) wide particle size distribution and poor separation effect (4) The same type of resin produced by the same manufacturer has large differences in specific surface area and functional group content between batches, and poor reproducibility in the purification of traditional Chinese medicine components.
发明内容Summary of the invention
为了解决上述问题,本发明提供一种精制的西洋参总皂苷组分及纯化制备西洋参总皂苷的方法,纯化制备方法包括以下步骤:In order to solve the above-mentioned problems, the present invention provides a refined American ginseng total saponins component and a method for purifying and preparing the American ginseng total saponins. The purification preparation method includes the following steps:
(1)提取和浓缩干燥:将西洋参药材洗净、干燥、粉碎,加30~80%乙醇进行煎煮0.1-5h,滤取药液;药渣再加30~80%乙醇煎煮0.1-3h,滤取药液,弃去药渣,合并两次药液即得西洋参粗提液;进行旋蒸、浓缩干燥,即得西洋参粗提干粉;(1) Extraction, concentration and drying: Wash, dry, pulverize American ginseng medicinal materials, add 30-80% ethanol for decocting for 0.1-5h, filter out the liquid; add 30-80% ethanol for decocting the medicinal residue for 0.1-3h , Filter the medicinal liquid, discard the medicinal residue, combine the two medicinal liquids to obtain the crude American ginseng extract; perform rotary steaming, concentration and drying to obtain the crude American ginseng dry powder;
(2)精纯:将西洋参粗提液通过过滤膜去颗粒物,采用高效液相色谱技术进行精制制备,收集柱洗脱液,得精制西洋参总皂苷组分,将其浓缩干燥,即得西洋参精制粉末;(2) Purification: Pass the crude extract of American ginseng through a filter membrane to remove particles, and use high-performance liquid chromatography for purification preparation. Collect the column eluate to obtain the refined total saponins of American ginseng, which is concentrated and dried to obtain refined American ginseng powder;
(3)脱色除杂:采用离子交换色谱技术对精制西洋参总皂苷组分进行脱色除杂,收集柱流穿液,得纯度较高的总皂苷组分;将其浓缩干燥,即得西洋参总皂苷纯品粉末。(3) Decolorization and impurity removal: Ion exchange chromatography is used to decolorize and remove impurities in the refined total saponins of American ginseng, collect the column flow-through liquid to obtain the total saponins with higher purity; condense and dry them to obtain the total saponins of American ginseng Pure powder.
更进一步的,在步骤(2)中,过滤膜的种类为有机膜或者无机膜,膜组件为平板膜、管式膜、中空纤维膜或卷式,孔径为750kD~1000kD、0.1-0.65μm;高效液相色谱技术所用反相色谱柱的填料基质为硅胶或高分子聚合物;填料配基的碳原子数为1~30的正链烷基中的一种或多种;色谱柱内径为20mm~1600mm,色谱柱床高度为100mm~1000mm;色谱平衡液中含有有机溶剂;色谱柱的载样量为固定相重量的0.01%~60%;色谱的上样和洗脱流速为140cm/h~350cm/h;色谱纯化洗脱总皂苷目标组分的有机溶剂浓度为30~90%,洗脱方式是等度或线性梯度。Furthermore, in step (2), the type of the filtration membrane is an organic membrane or an inorganic membrane, the membrane module is a flat membrane, a tubular membrane, a hollow fiber membrane or a roll type, and the pore size is 750kD~1000kD, 0.1-0.65μm; The packing matrix of the reversed-phase chromatographic column used in high performance liquid chromatography technology is silica gel or high molecular polymer; one or more of the normal chain alkyl groups with 1-30 carbon atoms of the packing ligand; the inner diameter of the chromatographic column is 20mm ~1600mm, the height of the chromatographic column bed is 100mm~1000mm; the chromatographic balance liquid contains organic solvent; the sample loading amount of the chromatographic column is 0.01%~60% of the weight of the stationary phase; the sample loading and elution flow rate of the chromatogram is 140cm/h~ 350cm/h; the organic solvent concentration for chromatographic purification and elution of the total saponin target component is 30-90%, and the elution method is isocratic or linear gradient.
更进一步的,步骤(3)中离子交换色谱技术所用分离材料的基质为琼脂糖、硅胶或高分子聚合物;粒径为40-100μm;配基的结构式为Furthermore, in step (3), the matrix of the separation material used in the ion exchange chromatography technique is agarose, silica gel or high molecular polymer; the particle size is 40-100 μm; the structural formula of the ligand is
上样体积为柱体积的10~60倍;色谱操作的上样和洗脱流速可以为150~500cm/h;色谱纯化目标组分的方式为流穿或洗脱模式。The loading volume is 10-60 times the column volume; the loading and elution flow rate for chromatographic operation can be 150-500cm/h; the method of chromatographic purification of target components is flow-through or elution mode.
更进一步的,在步骤(1)-(3)中所用浓缩干燥方式可以为减压干燥、微波干燥、冷冻干燥、真空干燥或喷雾干燥。Furthermore, the concentrated drying method used in steps (1)-(3) may be vacuum drying, microwave drying, freeze drying, vacuum drying or spray drying.
一种精制的西洋参总皂苷组分,原料主要组成为西洋参药材。A refined total saponin component of American ginseng, the main raw material is American ginseng medicinal materials.
本发明提供的一种精制的西洋参总皂苷组分及纯化制备西洋参总皂苷的方法,取得以下技术效果:The invention provides a refined Panax quinquefolium saponins component and a method for purifying and preparing Panax quinquefolium saponins, and achieves the following technical effects:
(1)用高效液相色谱分离技术与离子交换色谱分离技术联合使用,可有效的分离出人参皂苷,还可有效的去除色素、农药残留、重金属、内毒素等有毒有害物质,实现西洋参总皂苷的高效纯化制备,更适用于工业化生产;(1) The combined use of high performance liquid chromatography separation technology and ion exchange chromatography separation technology can effectively separate ginsenosides, and can also effectively remove pigments, pesticide residues, heavy metals, endotoxins and other toxic and harmful substances to achieve total saponins of American ginseng High-efficiency purification preparation, more suitable for industrial production;
(2)保留提高了活性成分含量,能最大化开发西洋参药材的药用价值;(2) The retention and improvement of the content of active ingredients can maximize the development of the medicinal value of American ginseng;
(3)采用精制的西洋参总皂苷,步骤2和3中获得的精制西洋参总皂苷粉相比于步骤1中获得的粗提干燥粉色泽均匀,表面光洁,粉质细腻;西洋参精制粉和最终纯品粉末加纯化水后迅速溶解,且其溶液澄清透亮,味清香甘美;而粗提干燥粉溶解速度缓慢且溶液浑浊,味苦涩;(3) Using refined American ginseng total saponins, the refined American ginseng total saponins powder obtained in steps 2 and 3 has a uniform pink color, a smooth surface and a finer powder quality compared to the crude extract obtained in step 1; The product powder dissolves quickly after adding purified water, and the solution is clear and bright, and the taste is sweet and sweet; while the crude dry powder dissolves slowly, the solution is turbid, and the taste is bitter;
(4)本发明提供的制备方法整个过程中,西洋参总皂苷相关的操作参数安全可控,受外界干扰因素较小,可显著提高产品的质量;(4) In the whole process of the preparation method provided by the present invention, the operating parameters related to the total saponins of American ginseng are safe and controllable, and the external interference factors are small, which can significantly improve the quality of the product;
(5)制备工艺操作简单、成本低,无需有毒有害的有机溶剂,洗脱剂和再生剂均可回收重复利用且对环境无害排放,可用于大规模生产。(5) The preparation process is simple in operation and low in cost, and does not require toxic and harmful organic solvents. The eluent and regenerant can be recycled and reused and are environmentally friendly and can be used for large-scale production.
图1为本发明中制备的西洋参粗提液的HPLC分析色谱图;Figure 1 is an HPLC analysis chromatogram of the crude extract of American ginseng prepared in the present invention;
图2为本发明中制备的西洋参总皂苷精制液的HPLC分析色谱图;Figure 2 is an HPLC analysis chromatogram of the refined solution of total saponins of Panax quinquefolium prepared in the present invention;
图3为本发明中制备的西洋参总皂苷纯品溶液的HPLC分析色谱图。Fig. 3 is an HPLC analysis chromatogram of the pure solution of Panax quinquefolium saponins prepared in the present invention.
下面将结合示意图对本发明的西洋参总皂苷精制物和纯品及其制备方法进行更详细的描述,其中表示了本发明的优选实施例,应该理解本领域技术人员可以修改在此描述的本发明,而仍然实现本发明的有利效果。因此,下列描述应当被理解为对于本领域技术人员的广泛知道,而并不作为对本发明的限制。In the following, the refined and pure Panax quinquefolium saponins of the present invention will be described in more detail in conjunction with the schematic diagram, and the preferred embodiments of the present invention are shown. It should be understood that those skilled in the art can modify the present invention described here. And still achieve the advantageous effects of the present invention. Therefore, the following description should be understood to be widely known to those skilled in the art, and not as a limitation to the present invention.
为了清楚,不描述实际实施例的全部特征。在下列描述中,不详细描述公知的功能和结构,因为它们会使本发明由于不必要的细节而混乱。应当认为在任何实际实施例的开发中,必须做出大量实施细节以实现开发者的特定目标,例如按照有关系统或有关商业的限制,由一个实施例改变为另一个实施例。另外,应当认为这种开发工作可能是复杂和耗费时间的,但是对于本领域技术人员来说仅仅是常规工作。For clarity, not all features of actual embodiments are described. In the following description, well-known functions and structures are not described in detail because they may confuse the present invention due to unnecessary details. It should be considered that in the development of any actual embodiment, a large number of implementation details must be made to achieve the developer's specific goal, such as changing from one embodiment to another in accordance with related system or related business restrictions. In addition, it should be considered that this kind of development work may be complicated and time-consuming, but it is only routine work for those skilled in the art.
在本发明中,除另有明确规定和限定,如有术语“第一”、“第二”仅用于描述目的,而不能理解为指示或暗示相对重要性或隐含指明技术特征的数量。由此,限定有“第一”、“第二”特征可以明示或者隐含包括一个或者多个该特征,在本发明描 述中,“至少”的含义是一个或一个以上,除非另有明确具体的限定。In the present invention, unless expressly stipulated and limited otherwise, the terms "first" and "second" are only used for descriptive purposes, and cannot be understood as indicating or implying relative importance or implicitly indicating the number of technical features. Therefore, the definition of “first” and “second” features may explicitly or implicitly include one or more of these features. In the description of the present invention, “at least” means one or more than one, unless otherwise clearly specified. The limit.
在下列段落中参照附图以举例方式更具体地描述本发明。根据下面说明,本发明的优点和特征将更清楚。需说明的是,附图均采用非常简化的形式且均使用非精准的比例,仅用以方便、明晰地辅助说明本发明实施例的目的。In the following paragraphs, the present invention is described in more detail by way of example with reference to the drawings. According to the following description, the advantages and features of the present invention will be clearer. It should be noted that the drawings are in a very simplified form and all use imprecise proportions, which are only used to conveniently and clearly assist in explaining the purpose of the embodiments of the present invention.
实施例一Example one
本发明提出一种提取西洋参总皂苷的纯化制备方法,具体步骤如下:The present invention provides a purification preparation method for extracting panax quinquefolium saponins, and the specific steps are as follows:
称取预处理好的西洋参药材100g,加入1L的65%乙醇水浴加热回流提取(90℃)3h,滤纸过滤,药渣加入0.8L的65%乙醇再次水浴加热回流提取(90℃)2h,纱布过滤,合并滤液;旋蒸浓缩后经喷雾干燥可得提取物干燥粉。将滤液进行HPLC分析,色谱分析结果如图1所示。Weigh 100g of pretreated American ginseng medicinal materials, add 1L of 65% ethanol water bath and heat reflux extraction (90℃) for 3h, filter with filter paper, add 0.8L 65% ethanol and then heat reflux extraction (90℃) 2h in water bath, gauze Filter and combine the filtrate; after rotary evaporation and concentration, spray-dried to obtain dry powder of the extract. The filtrate was analyzed by HPLC, and the chromatographic analysis result is shown in Figure 1.
将C18反相色谱柱(填料重量300g,粒径60μm)连接到高压液相系统上,设计流速60ml/min(190cm/h),采用5%乙醇平衡缓冲液冲洗色谱柱3BV,将西洋参粗提取液(使用0.22μm滤膜去除颗粒性不溶物)通过系统泵流经色谱柱纯化,通过5%乙醇淋洗杂质,60%乙醇洗脱目标物,收集各馏分进行HPLC分析,合格馏分合并,即为精制液。将精制液旋蒸去乙醇、真空干燥直至水分全部去除,收集干燥粉末,即为精制西洋参总皂苷粉末。精制液的HPLC分析结果见图2所示。Connect a C18 reverse phase chromatography column (filler weight 300g, particle size 60μm) to the high-pressure liquid system, design a flow rate of 60ml/min (190cm/h), flush the column 3BV with 5% ethanol equilibration buffer, and extract the American ginseng crudely The liquid (using a 0.22μm filter membrane to remove particulate insoluble matter) is purified by the system pump and passed through the chromatographic column. The impurities are eluted by 5% ethanol, and the target is eluted by 60% ethanol. The fractions are collected for HPLC analysis, and the qualified fractions are combined. For refined liquid. Rotate the refined liquid to remove the ethanol, vacuum dry until all the water is removed, and collect the dried powder, which is the refined American ginseng total saponin powder. Figure 2 shows the HPLC analysis results of the refined liquid.
取20g精制干燥粉用纯化水溶解,配置浓度100mg/mL。将WorkBeads 40TREN离子交换色谱柱(柱体积20mL)连接到层析系统上,设计流速12ml/min(360cm/h),将样品通过系统泵过平衡好的色谱柱,上样完毕后,纯水淋洗色谱柱,采用1M NaOH洗脱结合到色谱柱上的杂质。收集柱穿出液和淋洗液进行HPLC分析,即为高纯度西洋参总皂苷组分。将该馏分冷冻后放入冻干机中,抽真空干燥直至水分全部去除,收集冻干粉末,即为西洋参总皂苷纯品粉末。称重分析计算总皂苷含量。高纯度西洋参总皂苷组分溶液的HPLC分析结果见图3所示,皂苷含量约为72%,收率约为98%。Take 20g of refined dry powder and dissolve it in purified water to prepare a concentration of 100mg/mL. Connect the WorkBeads 40TREN ion exchange chromatography column (column volume 20mL) to the chromatography system, with a design flow rate of 12ml/min (360cm/h), and pump the sample through the system through the balanced column. After the sample is loaded, pure water Wash the chromatographic column and use 1M NaOH to elute the impurities bound to the chromatographic column. Collect the column effluent and eluent for HPLC analysis, which is the high-purity Panax quinquefolium saponins component. The fraction is frozen and placed in a freeze dryer, vacuum dried until all the water is removed, and the freeze-dried powder is collected, which is the pure powder of total saponins of American ginseng. Weighing analysis to calculate the total saponin content. The HPLC analysis result of the high-purity Panax quinquefolium total saponin component solution is shown in Figure 3. The saponin content is about 72%, and the yield is about 98%.
实施例二Example two
本发明提出一种提取西洋参总皂苷的纯化制备方法,具体步骤如下:The present invention provides a purification preparation method for extracting panax quinquefolium saponins, and the specific steps are as follows:
称取预处理好的西洋参药材100g,加入2L的70%乙醇水浴加热回流提取(90℃)2h,纱布过滤,药渣加入1L的70%乙醇再次水浴加热回流提取(90℃)2h,纱布过滤,合并滤液,旋蒸浓缩后经喷雾干燥得提取物干燥粉。Weigh 100g of the pretreated American ginseng medicinal materials, add 2L of 70% ethanol in a water bath and heat reflux (90℃) for 2h, filter with gauze, add 1L of 70% ethanol to the medicinal residue and extract again in a water bath (90℃) for 2h, filter with gauze , Combine the filtrate, spin-evaporate and concentrate, spray-dried to obtain a dry extract powder.
将C18反相色谱柱(填料重量300g,粒径30μm)连接到高压液相系统上,设 计流速60ml/min(190cm/h),采用纯水平衡缓冲液冲洗色谱柱3BV,将西洋参粗提取液(使用0.22μm滤膜去除颗粒性不溶物)通过系统泵流经色谱柱纯化,通过10%乙醇淋洗杂质,65%乙醇洗脱目标物,收集各馏分进行HPLC分析,合格馏分合并,即为精制液。将精制液旋蒸去除乙醇后冷冻,抽真空干燥直至水分全部去除,收集冻干粉末,即为精制西洋参总皂苷粉末。Connect a C18 reverse phase chromatography column (filler weight 300g, particle size 30μm) to the high-pressure liquid system, design a flow rate of 60ml/min (190cm/h), flush the column 3BV with pure water balance buffer, and remove the crude American ginseng extract (Use 0.22μm filter membrane to remove particulate insoluble matter) Purify through the chromatographic column through the system pump, rinse the impurities with 10% ethanol, and elute the target with 65% ethanol, collect each fraction for HPLC analysis, and combine the qualified fractions, that is Refined liquid. The refined liquid is revolved to remove the ethanol and then frozen, vacuum dried until all the water is removed, and the freeze-dried powder is collected, which is the refined American ginseng total saponin powder.
取20g精制干燥粉用纯化水溶解,配置浓度100mg/mL。将Q Sepharose 6FF离子交换色谱柱(柱体积20mL)连接到层析系统上,设计流速10ml/min(300cm/h),将样品通过系统泵过平衡好的色谱柱,上样完毕后,纯水淋洗色谱柱,采用1M NaOH和0.1M HCl洗脱结合到色谱柱上的杂质。收集柱穿出液和淋洗液进行HPLC分析,即为高纯度西洋参总皂苷组分。将该馏分冷冻后放入冻干机中,抽真空干燥直至水分全部去除,收集冻干粉末,即为西洋参总皂苷纯品粉末。称重分析计算总皂苷含量约为73%,收率约为97%。Take 20g of refined dry powder and dissolve it in purified water to prepare a concentration of 100mg/mL. Connect the Q Sepharose 6FF ion exchange chromatography column (column volume 20mL) to the chromatography system, with a design flow rate of 10ml/min (300cm/h), and pump the sample through the system through the balanced column. After the sample is loaded, pure water The chromatographic column is eluted, and the impurities bound to the chromatographic column are eluted with 1M NaOH and 0.1M HCl. Collect the column effluent and eluent for HPLC analysis, that is, the high-purity Panax quinquefolium saponins components. The fraction is frozen and placed in a freeze dryer, vacuum dried until all the water is removed, and the freeze-dried powder is collected, which is the pure powder of total saponins of American ginseng. Weighing analysis calculated that the total saponin content was about 73%, and the yield was about 97%.
实施例三Example three
本发明提出一种提取西洋参总皂苷的纯化制备方法,具体步骤如下:The present invention provides a purification preparation method for extracting panax quinquefolium saponins, and the specific steps are as follows:
称取预处理好的西洋参药材100g,加入1.5L的55%乙醇水浴加热回流提取(90℃)2h,纱布过滤,药渣加入1L的55%乙醇再次水浴加热回流提取(90℃)1h,纱布过滤,合并滤液,旋蒸浓缩后经喷雾干燥得提取物干燥粉。Weigh 100g of the pretreated American ginseng medicinal materials, add 1.5L of 55% ethanol in a water bath and heat reflux for extraction (90℃) for 2h, filter with gauze, add 1L of 55% ethanol, and extract again in a water bath (90℃) for 1h. Filter, combine the filtrate, spin-evaporate and concentrate, and spray-dry to obtain a dry powder of the extract.
将C18反相色谱柱(填料重量300g,粒径15μm)连接到高压液相系统上,设计流速50ml/min(150cm/h),采用10%乙醇平衡缓冲液冲洗色谱柱3BV,将西洋参粗提取液(使用0.22μm滤膜去除颗粒性不溶物)通过系统泵流经色谱柱纯化,通过线性梯度增加的方式(10-65%乙醇,45min)洗脱目标物,根据峰型收集各馏分进行HPLC分析,合格馏分合并,即为精制液。将精制液旋蒸浓缩后,抽真空干燥直至水分全部去除,收集冻干粉末,即为精制西洋参总皂苷粉末。Connect a C18 reverse phase chromatography column (filler weight 300g, particle size 15μm) to the high-pressure liquid system, design a flow rate of 50ml/min (150cm/h), wash the column 3BV with 10% ethanol equilibration buffer, and extract the American ginseng crudely The solution (using a 0.22μm filter membrane to remove particulate insolubles) is purified by the system pump and passed through the chromatographic column. The target is eluted by a linear gradient (10-65% ethanol, 45min), and each fraction is collected according to the peak type for HPLC After analysis, the qualified fractions are combined to form the refined liquid. After the refined liquid is concentrated by rotary evaporation, it is vacuum dried until all the water is removed, and the freeze-dried powder is collected, which is the refined total saponins powder of American ginseng.
取40g精制干燥粉用纯化水溶解,配置浓度50mg/mL。将WorkBeads 100TREN离子交换色谱柱(柱体积20mL)连接到层析系统上,设计流速12ml/min(360cm/h),将样品通过系统泵过平衡好的色谱柱,上样完毕后,纯水淋洗色谱柱,采用1M NaOH和0.1MHCl洗脱结合到色谱柱上的杂质。收集柱穿出液和淋洗液进行HPLC分析,即为高纯度西洋参总皂苷组分。将该馏分冷冻后放入冻干机中,抽真空干燥直至水分全部去除,收集冻干粉末,即为西洋参总皂苷纯品粉末。称重分析计算总皂苷含量约为70%,收率约为95%。Take 40g of refined dry powder and dissolve it in purified water to prepare a concentration of 50mg/mL. Connect the WorkBeads 100TREN ion exchange chromatography column (column volume 20mL) to the chromatography system with a design flow rate of 12ml/min (360cm/h). Pump the sample through the system through the balanced column. After the sample is loaded, pure water is poured. Wash the chromatographic column, and use 1M NaOH and 0.1M HCl to elute the impurities bound to the chromatographic column. Collect the column effluent and eluent for HPLC analysis, that is, the high-purity Panax quinquefolium saponins components. The fraction is frozen and placed in a freeze dryer, vacuum dried until all the water is removed, and the freeze-dried powder is collected, which is the pure powder of total saponins of American ginseng. Weighing analysis calculates that the total saponin content is about 70%, and the yield is about 95%.
实施例四Example four
本发明提出一种西洋参药材中总皂苷的制备方法,具体步骤如下:The present invention provides a method for preparing total saponins in American ginseng medicinal materials, and the specific steps are as follows:
称取预处理好的西洋参药材100g,加入1.5L的65%乙醇水浴加热回流提取(90℃)1h,纱布过滤,药渣加入1L的55%乙醇再次水浴加热回流提取(90℃)1h,纱布过滤,合并滤液,旋蒸浓缩后经喷雾干燥得提取物干燥粉。Weigh 100g of pretreated American ginseng medicinal materials, add 1.5L of 65% ethanol in a water bath and heat under reflux for extraction (90℃) for 1h, filter with gauze, add 1L of 55% ethanol and extract again in a water bath with reflux (90℃) for 1h, gauze Filter, combine the filtrate, spin-evaporate and concentrate, and spray-dried to obtain a dry extract powder.
将C18反相色谱柱(填料重量300g,粒径30μm)连接到高压液相系统上,设计流速60ml/min(190cm/h),采用5%乙醇平衡缓冲液冲洗色谱柱3BV,将西洋参粗提取液(使用0.22μm滤膜去除颗粒性不溶物)通过系统泵流经色谱柱纯化,通过15%乙醇淋洗杂质,70%乙醇洗脱目标物,收集各馏分进行HPLC分析,合格馏分合并,即为精制液。将精制液理性浓缩干燥直至水分全部去除,收集干燥粉末,即为精制西洋参总皂苷粉末。Connect the C18 reverse phase chromatography column (filler weight 300g, particle size 30μm) to the high pressure liquid system, design flow rate 60ml/min (190cm/h), flush the column 3BV with 5% ethanol balance buffer, and extract the American ginseng crudely The liquid (using a 0.22μm filter membrane to remove particulate insolubles) is purified by the system pump and passed through the chromatographic column. The impurities are eluted by 15% ethanol, and the target is eluted with 70% ethanol. The fractions are collected for HPLC analysis, and the qualified fractions are combined. For refined liquid. The refined liquid is concentrated and dried until all the water is removed, and the dried powder is collected, which is the refined American ginseng total saponin powder.
取30g精制干燥粉用纯化水溶解,配置浓度100mg/mL。将WorkBeads 40Q离子交换色谱柱(柱体积20mL)连接到层析系统上,设计流速12ml/min(360cm/h),将样品通过系统泵过平衡好的色谱柱,上样完毕后,纯水淋洗色谱柱,采用1M NaOH和0.1M HCl洗脱结合到色谱柱上的杂质。收集柱穿出液和淋洗液进行HPLC分析,即为高纯度西洋参总皂苷组分。将该馏分冷冻后放入冻干机中,抽真空干燥直至水分全部去除,收集冻干粉末,即为西洋参总皂苷纯品粉末。称重分析计算总皂苷含量约为68%,收率约为97%。Take 30g of refined dry powder and dissolve it in purified water to prepare a concentration of 100mg/mL. Connect the WorkBeads 40Q ion exchange chromatography column (column volume 20mL) to the chromatography system, with a design flow rate of 12ml/min (360cm/h), and pump the sample through the system through the balanced column. After the sample is loaded, pure water Wash the chromatographic column and use 1M NaOH and 0.1M HCl to elute the impurities bound to the chromatographic column. Collect the column effluent and eluent for HPLC analysis, which is the high-purity Panax quinquefolium saponins component. The fraction is frozen and placed in a freeze dryer, vacuum dried until all the water is removed, and the freeze-dried powder is collected, which is the pure powder of total saponins of American ginseng. Weighing analysis calculated that the total saponin content was about 68%, and the yield was about 97%.
上述各实施例中,HPLC分析条件如下:In the above embodiments, the HPLC analysis conditions are as follows:
(1)色谱柱填料:Unitary C18(5μm,4.6*150mm);(1) Chromatographic column packing: Unitary C18 (5μm, 4.6*150mm);
(2)流动相A:水,流动相B:乙腈;(2) Mobile phase A: water, mobile phase B: acetonitrile;
(3)流速:1ml/min;(3) Flow rate: 1ml/min;
(4)梯度条件:0-25min 20%B相,25-50min从20-46%B相,50-60min从46-55%B相,65min 55%B相。(4) Gradient conditions: 0-25min 20% phase B, 25-50min from 20-46% phase B, 50-60min from 46-55% phase B, 65min 55% phase B.
(5)柱温:25℃;(5) Column temperature: 25℃;
(6)检测波长:203nm;(6) Detection wavelength: 203nm;
(7)进样体积:10μl。(7) Injection volume: 10μl.
本发明还提出一种精制的西洋参总皂苷组分,原料主要组成为西洋参药材,经上述各实施例中的制备方法精制,步骤2和3中获得的精制西洋参总皂苷粉相比于步骤1中获得的粗提干燥粉色泽均匀,表面光洁,粉质细腻;西洋参精制粉和最终纯品粉末加纯化水后迅速溶解, 且其溶液澄清透亮,味清香甘美;而粗提干燥粉溶解速度缓慢且溶液浑浊,味苦涩。The present invention also provides a refined American ginseng total saponins component, the raw material is mainly composed of American ginseng medicinal materials, refined by the preparation methods in the above embodiments, the refined American ginseng total saponins powder obtained in steps 2 and 3 is compared with that in step 1. The obtained crude dry powder has uniform pink color, smooth surface and fine powder quality; the refined powder of American ginseng and the final pure product powder are quickly dissolved after adding purified water, and the solution is clear and bright, and the taste is sweet and sweet; while the dissolving speed of the crude dry powder is slow and The solution is cloudy and tastes bitter.
如图1、2、3所示,各步骤中的HPLC分析结果表明,纯化前后样品的分析谱图中目标峰没有显著变化,根据总体积、积分峰面积及重量计算得知,纯化后西洋参总皂苷精制物和纯品中主要成分的含量没有明显下降,总皂苷类物质收率达95%以上,纯度可达68%以上,和现有技术对比如表1所示。上述实验结果表明了,采用本发明中西洋参总皂苷精制物及纯品的纯化方法制备,获得的西洋参总皂苷具有高收率和高纯度的优势。As shown in Figures 1, 2, and 3, the HPLC analysis results in each step showed that the target peak in the analysis spectrum of the sample before and after purification did not change significantly. According to the calculation of the total volume, integrated peak area and weight, the total of American ginseng after purification The content of the main components in the refined and pure saponins did not decrease significantly, the yield of total saponins reached more than 95%, and the purity could reach more than 68%. The comparison with the prior art is shown in Table 1. The above-mentioned experimental results show that the obtained Panax quinquefolium saponins have the advantages of high yield and high purity by using the method for preparing the refined and pure Panax quinquefolium saponins of the present invention.
上述仅为本发明的优选实施例而已,并不对本发明起到任何限制作用。任何所属技术领域的技术人员,在不脱离本发明的技术方案的范围内,对本发明揭露的技术方案和技术内容做任何形式的等同替换或修改等变动,均属未脱离本发明的技术方案的内容,仍属于本发明的保护范围之内。The foregoing are only preferred embodiments of the present invention, and do not play any restrictive effect on the present invention. Any person skilled in the art, without departing from the scope of the technical solution of the present invention, makes any form of equivalent replacement or modification and other changes to the technical solution and technical content disclosed by the present invention, which does not depart from the technical solution of the present invention. The content still falls within the protection scope of the present invention.
表1本发明实施例和现有技术制备方法得到的总皂苷含量和收率比较Table 1 Comparison of total saponin content and yield obtained by the embodiment of the present invention and the prior art preparation method
制备方法Preparation | 总皂苷含量(%)Total saponin content (%) | 皂苷总收率(%)Total yield of saponin (%) |
实施例一Example one | 7272 | 9898 |
实施例二Example two | 7373 | 9797 |
实施例三Example three | 7070 | 9595 |
实施例四Example four | 6868 | 9797 |
现有技术current technology | 30-5030-50 | 75-8575-85 |
由表1可知,本发明提供的制备方法和现有技术相比,本发明提供的制备方法得到的总皂苷的含量和收率都远远高于现有技术,显然,本发明提供的制备方法能够得到更好的产品和更好的技术效果。It can be seen from Table 1 that, compared with the prior art, the preparation method provided by the present invention has a much higher total saponin content and yield than the prior art. Obviously, the preparation method provided by the present invention Can get better products and better technical effects.
对于本领域技术人员而言,显然本发明不限于上述示范性实施例的细节,而且在不背离本发明的精神或基本特征的情况下,能够以其他的具体形式实现本发明。因此,无论从哪一点来看,均应将实施例看作是示范性的,而且是非限制性的,本发明的范围由所附权利要求而不是上述说明限定,因此旨在将落在权利要求的等同要件的含义和范围内的所有变化囊括在本发明内。不应将权利要求中的任何附图标记视为限制所涉及的权利要求。For those skilled in the art, it is obvious that the present invention is not limited to the details of the above exemplary embodiments, and the present invention can be implemented in other specific forms without departing from the spirit or basic characteristics of the present invention. Therefore, from any point of view, the embodiments should be regarded as exemplary and non-limiting. The scope of the present invention is defined by the appended claims rather than the above description, and therefore it is intended to fall within the claims. All changes within the meaning and scope of the equivalent elements of are included in the present invention. Any reference signs in the claims should not be regarded as limiting the claims involved.
Claims (7)
- 一种提取西洋参总皂苷的纯化制备方法,其特征在于,步骤如下:A purification preparation method for extracting total saponins of American ginseng, which is characterized in that the steps are as follows:(1)提取和浓缩干燥:将西洋参药材洗净、干燥、粉碎,加30~80%乙醇进行煎煮0.1-5h,滤取药液;药渣再加30~80%乙醇煎煮0.1-3h,滤取药液,弃去药渣,合并两次药液即得西洋参粗提液;进行旋蒸浓缩、干燥,即得西洋参粗提干粉;(1) Extraction, concentration and drying: Wash, dry, pulverize American ginseng medicinal materials, add 30-80% ethanol for decocting for 0.1-5h, filter out the liquid; add 30-80% ethanol for decocting the medicinal residue for 0.1-3h , Filtrate the medicinal solution, discard the medicinal residue, combine the two medicinal solutions to obtain the crude American ginseng extract; perform rotary evaporation and concentration and drying to obtain the crude American ginseng dry powder;(2)精纯:将西洋参粗提液通过过滤膜去颗粒物,采用高效液相色谱技术进行精制制备,收集柱洗脱液,得精制西洋参总皂苷组分,将其浓缩干燥,即得西洋参精制粉末;(2) Purification: Pass the crude extract of American ginseng through a filter membrane to remove particles, and use high-performance liquid chromatography for purification preparation. Collect the column eluate to obtain the refined total saponins of American ginseng, which is concentrated and dried to obtain refined American ginseng powder;(3)脱色除杂:采用离子交换色谱技术对精制西洋参总皂苷组分进行脱色除杂,收集柱流穿液,得高纯度的总皂苷组分;将其浓缩干燥,即得西洋参总皂苷纯品粉末。(3) Decolorization and impurity removal: Ion exchange chromatography is used to decolorize and remove impurities from the refined total saponins of American ginseng, collect the column flow-through to obtain high-purity total saponins; concentrate and dry it to obtain pure saponins品粉。 Product powder.
- 根据权利要求1所述一种提取西洋参总皂苷的纯化制备方法,其特征在于:在步骤(2)中,所述过滤膜的种类为有机膜或者无机膜,膜组件为平板膜、管式膜、中空纤维膜或卷式,孔径为750kD~1000kD、0.1~0.65μm。The purification preparation method for extracting total saponins of American ginseng according to claim 1, characterized in that: in step (2), the type of the filter membrane is an organic membrane or an inorganic membrane, and the membrane module is a flat membrane or a tubular membrane. , Hollow fiber membrane or roll type, pore size is 750kD~1000kD, 0.1~0.65μm.
- 根据权利要求1所述一种提取西洋参总皂苷的纯化制备方法,其特征在于,在步骤(2)中,高效液相色谱技术的填料基质为硅胶或高分子聚合物;填料配基的碳原子数为1~30的正链烷基中的一种或多种;色谱柱内径为20mm~1600mm,色谱柱床高度为100mm~1000mm;色谱平衡液中含有有机溶剂;色谱柱的载样量为固定相重量的0.01%~60%;色谱的上样和洗脱流速为140cm/h~350cm/h;色谱纯化洗脱总皂苷目标组分的有机溶剂浓度为30~90%,洗脱方式可以是等度或线性梯度。The purification preparation method for extracting total saponins of American ginseng according to claim 1, characterized in that, in step (2), the filler matrix of high performance liquid chromatography is silica gel or high molecular polymer; the carbon atoms of the filler ligand One or more of the normal chain alkyl groups of 1-30; the inner diameter of the chromatographic column is 20mm~1600mm, the height of the chromatographic column bed is 100mm~1000mm; the chromatographic balance liquid contains organic solvent; the sample load of the chromatographic column is 0.01% to 60% of the weight of the stationary phase; the loading and elution flow rate of the chromatogram is 140 cm/h to 350 cm/h; the organic solvent concentration of the chromatographic purification and elution total saponin target component is 30 to 90%, the elution method can Is an isocratic or linear gradient.
- 根据权利要求3所述一种提取西洋参总皂苷的纯化制备方法,其特征在于,所述有机溶剂为甲醇、乙醇或乙腈,有机溶剂的含量为5%~20%。The purification preparation method for extracting total saponins of American ginseng according to claim 3, wherein the organic solvent is methanol, ethanol or acetonitrile, and the content of the organic solvent is 5%-20%.
- 根据权利要求1所述一种提取西洋参总皂苷的纯化制备方法,其特征在于,步骤(3)中所用得离子交换色谱技术所用分离材料的基质为琼脂糖、硅胶或高分子聚合物;粒径为40~100μm;配基的结构式为 The purification preparation method for extracting total saponins of American ginseng according to claim 1, wherein the matrix of the separation material used in the ion exchange chromatography technique used in step (3) is agarose, silica gel or high molecular polymer; Is 40~100μm; the structural formula of the ligand is上样体积为柱体积的10~60倍;色谱操作的上样和洗脱流速可以为150~500cm/h;色谱纯化目标组分的方式为流穿或者洗脱模式。The loading volume is 10-60 times the column volume; the loading and elution flow rate for chromatographic operation can be 150-500 cm/h; the method of chromatographic purification of target components is flow-through or elution mode.
- 根据权利要求1所述一种提取西洋参总皂苷的纯化制备方法,其特征在于,在步骤(1)~(3)中所用浓缩干燥方式为减压干燥、微波干燥、冷冻干燥、真空干燥或喷雾干燥。The method for purification and preparation of extracting total saponins of American ginseng according to claim 1, wherein the concentration and drying method used in steps (1) to (3) is vacuum drying, microwave drying, freeze drying, vacuum drying or spraying dry.
- 一种采用上述制备方法精制的西洋参总皂苷组分,其特征在于,原料主要组成为西洋参药材。The American ginseng total saponin component refined by the above preparation method is characterized in that the main raw material is American ginseng medicinal materials.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910245968.3A CN110974858A (en) | 2019-03-28 | 2019-03-28 | Refined American ginseng total saponin component and method for purifying and preparing American ginseng total saponin |
CN201910245968.3 | 2019-03-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2020192163A1 true WO2020192163A1 (en) | 2020-10-01 |
Family
ID=70081552
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2019/121266 WO2020192163A1 (en) | 2019-03-28 | 2019-11-27 | Refined american ginseng total saponin component and method for purifying and preparing american ginseng total saponin |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN110974858A (en) |
WO (1) | WO2020192163A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117946197A (en) * | 2024-01-16 | 2024-04-30 | 唐宁医药科技(济南)有限公司 | Extraction method and application of saponin component in American ginseng stem and leaf |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1490326A (en) * | 2003-08-29 | 2004-04-21 | 沈阳药科大学 | Triterpene saponins in the stems and leaves of American ginseng and its medicinal use and preparation method |
CN1513461A (en) * | 2003-07-17 | 2004-07-21 | 吉林省中医中药研究院 | Feeze-dried powder injection contg. tatol saponin by refinement of American ginseng and leaves and stem of Americal ginseng, and its prodn. process |
CN101084954A (en) * | 2006-06-08 | 2007-12-12 | 天津天士力之骄药业有限公司 | Method for preparing American ginseng total saponins |
CN102772462A (en) * | 2011-05-11 | 2012-11-14 | 河北以岭医药研究院有限公司 | Method for extracting and separating total saponins of panax ginseng from american ginseng |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4773512B2 (en) * | 2005-04-26 | 2011-09-14 | コ,ブン−キョン | Extraction method of ginseng saponin Rg2, pharmaceutical composition containing the extract and use thereof |
-
2019
- 2019-03-28 CN CN201910245968.3A patent/CN110974858A/en active Pending
- 2019-11-27 WO PCT/CN2019/121266 patent/WO2020192163A1/en active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1513461A (en) * | 2003-07-17 | 2004-07-21 | 吉林省中医中药研究院 | Feeze-dried powder injection contg. tatol saponin by refinement of American ginseng and leaves and stem of Americal ginseng, and its prodn. process |
CN1490326A (en) * | 2003-08-29 | 2004-04-21 | 沈阳药科大学 | Triterpene saponins in the stems and leaves of American ginseng and its medicinal use and preparation method |
CN101084954A (en) * | 2006-06-08 | 2007-12-12 | 天津天士力之骄药业有限公司 | Method for preparing American ginseng total saponins |
CN102772462A (en) * | 2011-05-11 | 2012-11-14 | 河北以岭医药研究院有限公司 | Method for extracting and separating total saponins of panax ginseng from american ginseng |
Non-Patent Citations (1)
Title |
---|
WANG; DONGXUE: "Study on Extraction Process of Total Saponins from Panax quinquefolius L", HEILONGJIANG SCIENCE AND TECHNOLOGY INFORMATION, no. 4, 31 December 2016 (2016-12-31), CN, pages 139 - 140, XP009523702, ISSN: 1673-1328 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117946197A (en) * | 2024-01-16 | 2024-04-30 | 唐宁医药科技(济南)有限公司 | Extraction method and application of saponin component in American ginseng stem and leaf |
Also Published As
Publication number | Publication date |
---|---|
CN110974858A (en) | 2020-04-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102258588B (en) | Preparation method of peony general glycoside | |
CN102423329B (en) | A kind of discoloration method of panax notoginsenoside extract | |
CN111329905A (en) | Total alkaloid component extracted from coptis chinensis and refining method thereof | |
CN108042590A (en) | A kind of residual extract of Radix Ginseng stem and leaf of low agriculture and preparation method thereof | |
CN102824394B (en) | Method for synchronously extracting and separating icariin and icarisid II from herba epimedii | |
CN109879919B (en) | A kind of method for separating and preparing three kinds of flavonoid glycosides from jujube seed | |
WO2020192163A1 (en) | Refined american ginseng total saponin component and method for purifying and preparing american ginseng total saponin | |
CN102924537B (en) | Method for preparing hyperoside and isoquercitrin simultaneously from dogbane leaves | |
CN101402577A (en) | Method for extracting and separating levorotation-synephrine from green tangerine orange peel | |
WO2020113450A1 (en) | Preparation method for pseudo-ginseng total saponins by means of extraction and purification | |
CN109694366B (en) | Method for separating and purifying active ingredients of clematis filamentosa dunn | |
CN101318955B (en) | Method for preparing effective component of kudzu root | |
CN110437059A (en) | A method of extraction prepares pachymic acid A and pachymic acid B from fuling peel | |
CN101084967A (en) | Extracting and purifying technology for safflower flavonoids | |
CN112010911A (en) | Method for purifying total ginsenoside | |
CN112225765A (en) | A kind of purification method and application of sennoside A | |
CN103524579B (en) | A kind of method utilizing three column chromatography technologies sharp separation Catalpol from glutinous rehmannia | |
CN101955501B (en) | Method for extracting and separating high-purity salidroside in pilot scale | |
CN103044253B (en) | Extraction separation method of rosmarinic acid in salvia castabea diels f. tomentosa stib | |
CN108101952A (en) | A kind of preparation method of ginsenoside Re and Rd | |
CN1321995C (en) | Total coptis alkaloid preparation method | |
CN109336942B (en) | Method for extracting purified panax japonicus saponin VI from ginseng | |
CN117815351A (en) | Preparation method of lung-heat clearing and toxin expelling granule | |
CN105801656B (en) | The method that Rg1, Re and Rb1 are purified from arasaponin | |
CN105732653A (en) | Method for preparing oridonin from isodon japonica |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 19921156 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 19921156 Country of ref document: EP Kind code of ref document: A1 |